Physician profile
Alan Fu Lien
NPI 1467950493
$11,626.98
in general payments reported to CMS, 2019-2025
36 companies · $3,474 in 2025
The $3,474 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,424 · 2022: $1,338 · 2023: $1,386 · 2024: $4,005 · 2025: $3,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,320 · Education: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,319.97 |
| Education | $544.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,772.04 | 2022-2025 | |
| Incyte Corporation | $1,257.27 | 2023-2025 | Opzelura, Opzelura, Iclusig |
| Janssen Biotech, INC. | $1,195.88 | 2021-2025 | Tremfya |
| Dermavant Sciences, INC. | $915.30 | 2022-2024 | Vtama |
| Amgen INC. | $839.87 | 2021-2025 | Otezla, Otezla |
| Janssen Scientific Affairs, LLC | $700.62 | 2022-2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $574.94 | 2023-2025 | Zoryve |
| Genzyme Corporation | $574.10 | 2022-2025 | |
| Astellas Pharma US INC | $479.28 | 2021-2022 | |
| Verrica Pharmaceuticals INC. | $447.80 | 2024-2025 | Ycanth |
| Ucb, INC. | $377.95 | 2022-2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $285.53 | 2022-2025 | Winlevi |
| Regeneron Healthcare Solutions, INC. | $213.07 | 2022-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $183.84 | 2022-2024 | Sotyktu |
| Boston Scientific Corporation | $169.47 | 2021-2024 | Spaceoar Vue System - 10ml, Rezum Generator |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $164.15 | 2025 | Anzupgo, Adbry |
| Antares Pharma, INC. | $152.63 | 2021 | |
| Organon LLC | $136.81 | 2025 | Vtama, Nexplanon |
| Emd Serono, INC. | $129.87 | 2025 | |
| Dendreon Pharmaceuticals LLC | $122.11 | 2021 | |
| Endo Pharmaceuticals INC. | $121.71 | 2021 | |
| Lilly USA, LLC | $110.71 | 2025 | Ebglyss, Taltz |
| Galderma Laboratories, L.P. | $100.71 | 2025 | Nemluvio |
| Coloplast Corp | $78.44 | 2021-2022 | |
| 180 Medical, INC. | $67.68 | 2021-2022 | |
| Myovant Sciences INC. | $66.31 | 2021 | |
| Alnylam Pharmaceuticals INC. | $63.02 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.22 | 2021 | |
| Myriad Genetic Laboratories, INC. | $46.84 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $44.51 | 2021 | |
| Novartis Pharmaceuticals Corporation | $42.35 | 2023-2024 | |
| Urovant Sciences INC | $38.46 | 2021-2022 | |
| Allergan, INC. | $32.39 | 2022 | |
| Botanix Sb INC | $21.89 | 2025 | Sofdra |
| Pfizer INC. | $19.77 | 2021 | |
| Blue Earth Diagnostics | $19.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Lien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.